Drugs / BI 1021958
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02202512 | Sep → Dec 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01638598 | Jul → Aug 2012 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01629849 | Jul → Dec 2012 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01541488 | Feb → May 2012 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 1021958 | “Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers” NCT01638598 ↗ |
| Route | Oral | “Single Rising Oral Doses” NCT01541488 ↗ |